These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 2046079)
21. [Clinical use of an estrogen-gestagen combination drug for the inhibition of ovulation]. Janisch H; Müller-Tyl E Wien Med Wochenschr; 1974 Sep; 124(37):533-6. PubMed ID: 4408941 [No Abstract] [Full Text] [Related]
22. Oral contraceptives and coronary artery atherosclerosis of cynomolgus monkeys. Clarkson TB; Shively CA; Morgan TM; Koritnik DR; Adams MR; Kaplan JR Obstet Gynecol; 1990 Feb; 75(2):217-22. PubMed ID: 2300348 [TBL] [Abstract][Full Text] [Related]
28. [Clinical study of low-dose oral contraceptives (with low-doses of ethinyl estradiol), widely used in practice]. Nalbanski B; Tsekova K; Ivanov S Akush Ginekol (Sofiia); 2001; 41 Suppl 4():20-3. PubMed ID: 11519317 [No Abstract] [Full Text] [Related]
29. [Influence of progestins on adverse effects of oral contraceptives]. Wynn V Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210 [TBL] [Abstract][Full Text] [Related]
30. [Lupic syndrome and estroprogestative drugs]. Cordonnier V; de Beer P; Lundy-Mahieu J Sci Med Lille; 1972 Dec; 90(12):431-2. PubMed ID: 4121019 [TBL] [Abstract][Full Text] [Related]
31. [Preliminary results of comparative trials of oral contraceptives]. Arnold M; Mall-Haefeli M; Cloeren S; Morf E; Richter RH; Roth F; Stamm H; Wyss H; Weis P Gynaecologia; 1966; 162(5):447-52. PubMed ID: 5960452 [No Abstract] [Full Text] [Related]
32. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives. Norris LA; Bonnar J Thromb Haemost; 1994 Dec; 72(6):926-30. PubMed ID: 7740465 [TBL] [Abstract][Full Text] [Related]
33. Clinical trial of a monophasic estroprogestin oral formulation containing 20 micrograms ethinyl estradiol and 75 micrograms gestodene. Lello S; Monterubbianesi M; Guardianelli F; Bianchi C; Simonelli C Gynecol Endocrinol; 2001 Aug; 15(4):265-71. PubMed ID: 11560099 [TBL] [Abstract][Full Text] [Related]
34. Comparative data on the liver- and lipid metabolism influencing effects of Anteovin. Pilishegyi J Ther Hung; 1987; 35(2):71-6. PubMed ID: 3438865 [TBL] [Abstract][Full Text] [Related]
35. [Thrombelastography and oral contraceptives]. Delacrétaz-Dubugnon F Schweiz Med Wochenschr; 1972 Jan; 102(2):48-52. PubMed ID: 4644685 [No Abstract] [Full Text] [Related]
36. Long-term effects of female sex steroids on female rat liver in an initiator-promoter model of hepatocarcinogenesis. Annapurna VV; Mukundan MA; Sesikeran B; Bamji MS Indian J Biochem Biophys; 1988 Dec; 25(6):708-13. PubMed ID: 3255685 [No Abstract] [Full Text] [Related]
37. [Clinical experience with an estrogen-progestogen association with low estrogen content (ethinodiol-ethinylestradiol)]. Andreoli C; Fiorentino F; Lenzi G Quad Clin Ostet Ginecol; 1970 Jan; 25(1):15-28. PubMed ID: 5523807 [No Abstract] [Full Text] [Related]
38. [Colposcopic findings in women treated with oral estrogen-progestagens]. Gacci G Quad Clin Ostet Ginecol; 1968 Dec; 23(12):1575-80. PubMed ID: 5744200 [No Abstract] [Full Text] [Related]
39. Oral contraception with a biphasic tablet (observations with anteovin). Tallián F Ther Hung; 1986; 34(2):112-6. PubMed ID: 3449970 [No Abstract] [Full Text] [Related]